LabCompass

Adam Quick

Medicine · The Ohio State University

Mid career · publishing since 2002

Publications

50

Citations

1,487

Est. group size

Recurring co-author estimate

Active years

24

Publishing since 2002

Research summary
AI-generated

Adam Quick's work centers on amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease affecting nerve cells that control muscle movement, including clinical trials of experimental drugs, disease epidemiology, and genetic testing in ALS patients. He also has a parallel line of work in neurology medical education, focusing on training methods for medical students and residents. This profile suggests a clinician-researcher role that combines patient-oriented ALS research with efforts to improve how neurology is taught.

Amyotrophic lateral sclerosis (ALS) clinical trialsALS genetics and epidemiologyNeurology medical education and resident trainingNeuromuscular and neurogenetic disordersClinical diagnostic case reports

Publication output has fluctuated over the past decade with no clear long-term growth or decline, showing peaks around 2020, 2023, and 2025 and a low point in 2024, averaging about 3 publications per year over the last 5 years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.0/year recently
2017: 3 publications172018: 2 publications182019: 4 publications192020: 6 publications6202021: 5 publications212022: 3 publications222023: 6 publications6232024: 1 publication242025: 5 publications2526
Recent publications
Publishes in
  • Neurology×16
  • Muscle & Nerve×2
  • JAMA×2
  • JAMA Neurology×2
  • Neurology Genetics×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile